Bristol Myers Squibb

In honor of #Heartmonth and to encourage women’s heart health, we hosted our first-ever “Bring Your M.O.M. to Work Day”. We celebrated the incredible 𝐌others 𝐎r 𝐌ost important women for members of our workforce through meaningful conversations, connection, and cardiovascular education with the Bristol Myers Squibb Network of Women (B-NOW) and WomenHeart: The National Coalition for Women with Heart Disease. Heart disease remains the leading cause of death globally for women and we are committed to advancing heart health, providing access to education and care to help improve the lives of patients. #OneBMS

See memorable moments from the Black Organization for Leadership and Development (BOLD)’s #BlackHistoryMonth celebrations centered around the theme “Amplifying Our Voices,” like the conversation with our Rondu Vincent and Janice Bryant Howroyd — the first African American woman to build a $1 billion dollar company — and a performance by the BOLD choir. Listen to the BOLD Innovators podcast to learn how they foster an inclusive environment for our communities and patients: https://bit.ly/3QE26W1

This year’s #ACTRIMSForum marks an exciting step forward in BMS’ pioneering efforts to bring the science of #CARTcelltherapy into a new frontier. Today, we are presenting Phase 1 results evaluating our CD19-directed cell therapy asset in #MultipleSclerosis (MS). While early, this data indicates the potential for #CARTcelltherapy to offer a new treatment avenue to address unmet needs in progressive, autoimmune diseases, including MS. We are committed to bringing together experts, researchers and patient advocates to take ACTioN and expand the science of cell therapy into autoimmune and neuroinflammatory diseases. Learn more. https://bit.ly/4kgsWkM #OneBMS

The convergence of human ingenuity and cutting-edge technology is fueling our predictive power and ushering in a new, exciting era of breakthroughs in drug discovery and development. See how we’re predicting new possibilities: https://bit.ly/3DmwqRX #OneBMS

We look forward to presenting new data regarding changes in cognitive functioning and brain volume following a one-year interim analysis of an approved treatment for patients living with #MultipleSclerosis (MS). As part of our commitment to #neuroscience, we are focused on empowering those with MS by working towards meaningful innovations with the goal of helping preserve physical and cognitive function. Explore our work in MS: https://bit.ly/4i9wWkX

At #ACTRIMSForum, we will deliver 11 presentations exploring new data on an approved and an investigational treatment for people living with #MultipleSclerosis (MS). As part of our commitment to #neuroscience, we are researching options that seek to address cognitive and physical health along a patient’s journey and innovate the treatment landscape for those impacted by MS. Learn more about our efforts to deliver meaningful innovations to the MS community: https://bit.ly/434EZez #OneBMS

This #HCMAwarenessDay, we are bringing attention to hypertrophic cardiomyopathy, a serious and chronic heart condition. By collaborating with experts, healthcare providers, advocacy groups and patient communities, we aim to bring meaningful change to those affected by HCM. Together we can turn awareness into action. HCM is the most common inherited heart disease in the United States and can affect anyone regardless of age, gender or ethnicity, yet it remains largely undiagnosed. We encourage you to take a moment to have an open conversation with a loved one about heart health and HCM. Share family health histories and ask questions. If something doesn’t feel right, consult a doctor. Early detection and proactive care can make all the difference. Learn more about HCM: https://bit.ly/42RNyt9 #OneBMS

Our scientists are collaborating with Johnson & Johnson Innovative Medicine to investigate ways to reduce the risk of heart attacks and strokes for people living with thrombotic conditions, like Dr. ShantaQuilette (Dr. Q) Develle, MBA, CPLC, MH, EA. Learn more about our FXIa research: https://bit.ly/4hQSALg #HeartMonth #OneBMS

At this week’s Winter Clinical Dermatology Conference - Hawaii, we’re presenting new five-year results on our oral medicine for the treatment of patients with moderate-to-severe plaque #psoriasis. Exchanging comprehensive updates on the treatment of dermatologic conditions, like psoriasis, and the latest advances in patient management is invaluable as we work to elevate new standards of care for patients. Explore our work in dermatology: https://bit.ly/40Np9DV #OneBMS

“Fostering an inclusive work environment drives innovation and increases patient access to medicines.” The Black Organization for Leadership and Development (BOLD) kicked off #BlackHistoryMonth with a fireside conversation about the power of using your voice for career growth and serving our patients and our communities. Chief I&D Officer Fernando Salinas moderated the conversation with Adrienne D Gonzalez, Carlon Burt, MBA, and Maurice Bellfield, joined by Chief People Officer Amanda Poole and BOLD Global lead Monique Phillips, PMP. Learn more about BOLD and our global People and Business Resource Groups that help us achieve our patient-focused mission: https://bit.ly/3ENrEx8